Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$4.02 USD
-0.12 (-2.90%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.04 +0.02 (0.50%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Earnings News For ABUS
-
Arbutus: Q2 Earnings Snapshot
-
Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
-
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
-
Arbutus: Q1 Earnings Snapshot
-
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
-
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
-
Arbutus: Q3 Earnings Snapshot
-
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q2 Loss, Lags Revenue Estimates
-
Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
-
Arbutus: Q1 Earnings Snapshot
-
Arbutus Reports First Quarter 2023 Financial Results and Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
-
Arbutus Reports Fourth Quarter and Year End 2022 Financial Results and Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
-
Arbutus: Q3 Earnings Snapshot
-
Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
-
Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
-
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
-
Arbutus Biopharma (ABUS) Reports Q3 Loss, Tops Revenue Estimates
-
Will Arbutus Biopharma (ABUS) Report Negative Earnings Next Week? What You Should Know